Skip to main content

Animations

MJFF Publications

1041 - 1050 of 9156 Results
Title
Year
  • Year
  • 2020
  • 2014
  • 2019
  • 2020
  • 2018
  • 2017
  • 2018
  • 2019
  • 2021
  • 2023
  • Summary Details
    RESTRICTED
    Title: Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-020-00914-6
    Citation Count: 58
  • Summary Details
    RESTRICTED
    Title: Manganism in the 21st century: The Hanninen lecture
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2013.09.007
    Citation Count: 65
  • Summary Details
    RESTRICTED
    Title: Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s disease
    Journal Name: Neuroscience & Biobehavioral Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: elsevier-specific: oa user license
    DOI - Digital Object Identifier: 10.1016/j.neubiorev.2019.05.016
    Citation Count: 95
  • Summary Details
    RESTRICTED
    Title: The Accumulation of Tau in Postsynaptic Structures: A Common Feature in Multiple Neurodegenerative Diseases?
    Journal Name: The Neuroscientist
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/1073858420916696
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Finding useful biomarkers for Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aam6003
    Citation Count: 119
  • Summary Details
    RESTRICTED
    Title: Alpha-synuclein oligomers: a new hope
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-017-1755-1
    Citation Count: 255
  • Summary Details
    RESTRICTED
    Title: Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1941-9
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Selective vulnerability in α-synucleinopathies
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-019-02010-2
    Citation Count: 59
  • Summary Details
    RESTRICTED
    Title: Periphery and brain, innate and adaptive immunity in Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02268-5
    Citation Count: 147
  • Summary Details
    RESTRICTED
    Title: Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-023-02557-1
    Citation Count: 22
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.